Evidence map›Paper›PMID 39633384›Full record

ArticleOrphanet journal of rare diseases2024

Systematic quantitative modeling of the natural history of Aicardi syndrome: A cross sectional study of 245 published cases.

Oliver Y Urban, Jan H Driedger, Sven F Garbade, Georg F Hoffmann, Stefan Kölker, Markus Ries, Steffen Syrbe

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Oliver Y UrbanDivision of Pediatric Epileptology, Center for Pediatric and Adolescent Medicine, Clinic 1, Medical Faculty of Heidelberg, Heidelberg University, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.
Jan H DriedgerDivision of Pediatric Epileptology, Center for Pediatric and Adolescent Medicine, Clinic 1, Medical Faculty of Heidelberg, Heidelberg University, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.ORCID 0000-0001-6915-7119
Sven F GarbadeDivision of Pediatric Neurology and Metabolic Medicine, Center for Pediatric and Adolescent Medicine, Clinic 1, Medical Faculty of Heidelberg, Heidelberg University, Heidelberg, Germany.
Georg F HoffmannDivision of Pediatric Neurology and Metabolic Medicine, Center for Pediatric and Adolescent Medicine, Clinic 1, Medical Faculty of Heidelberg, Heidelberg University, Heidelberg, Germany.
Stefan KölkerDivision of Pediatric Neurology and Metabolic Medicine, Center for Pediatric and Adolescent Medicine, Clinic 1, Medical Faculty of Heidelberg, Heidelberg University, Heidelberg, Germany.
Markus Ries *Division of Pediatric Neurology and Metabolic Medicine, Center for Pediatric and Adolescent Medicine, Clinic 1, Medical Faculty of Heidelberg, Heidelberg University, Heidelberg, Germany.ORCID 0000-0002-5054-5741
Steffen Syrbe *Division of Pediatric Epileptology, Center for Pediatric and Adolescent Medicine, Clinic 1, Medical Faculty of Heidelberg, Heidelberg University, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany. Steffen.Syrbe@med.uni-heidelberg.de.ORCID 0000-0003-2543-4844

Funding

Dietmar Hopp Stiftung 1DH1813319
6 · The paper itself

Abstract

purposeAicardi syndrome is a rare epileptic encephalopathy, almost exclusively affecting girls. It was first described as a triad of infantile spasms, chorioretinal defects and agenesis of the corpus callosum. The etiology remains unknown and there is uncertainty on best practice therapy and outcome. We aimed at defining quantitative clinical endpoints that will inform future research and clinical trials.

methodsQuantitative natural history modeling of cases with Aicardi syndrome from published clinical reports. Main outcome measures were age at disease onset, survival and diagnostic delay. Phenotypic features of affected individuals as well as neuroradiological and ophthalmological features were descriptively stated. STROBE criteria were respected.

resultsTwo hundred forty-five cases were available for analysis. Median age at disease onset was 2.2 months. Median diagnostic delay was 1 month. Mortality was estimated with 6% at 1 and 17% at 5 years of age. 60% of children showed the classic clinical features, while 40% met the revised diagnostic criteria. We delineate possible predictors of disease severity and of seizure control.

conclusionWe provide natural history data including geographical localization of 245 published patients with Aicardi syndrome. Quantitative history modeling in rare epileptic encephalopathies will help to raise disease awareness and facilitate future clinical trials as one core element of quantitative systems pharmacology.

Indexed as

Aicardi SyndromeChildChild, PreschoolCross-Sectional StudiesFemaleHumansInfantMaleAgenesis of corpus callosumAicardi syndromeChorioretinal lacunaeEpileptic encephalopathyInfantile spasmsNatural history

Identifiers

PMID39633384
PMCPMC11616230

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.